# Curanex Pharmaceuticals Inc (CURX)

Source: https://www.quantisnow.com/company/CURX
Generated: 2026-11-17T19:33:07.526Z

- Ticker: CURX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2025
- SEC CIK: 0002025942

## Latest CURX news and filings

- 2026-11-13 18:41 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-curanex-pharmaceuticals-inc-6790060)
- 2026-10-19 21:16 UTC [SEC Form S-8] [SEC Form S-8 filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-curanex-pharmaceuticals-inc-6750970)
- 2026-10-19 21:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-curanex-pharmaceuticals-inc-6750965)
- 2026-08-17 20:45 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-material-modification-to-6685241)
- 2026-08-14 16:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-curanex-pharmaceuticals-inc-6682495)
- 2026-07-21 20:25 UTC [SEC Form S-8] [SEC Form S-8 filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-curanex-pharmaceuticals-inc-6643963)
- 2026-06-29 14:18 UTC [SEC Form DEF 14C filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-def-14c-filed-by-curanex-pharmaceuticals-inc-6618598)
- 2026-06-18 21:12 UTC [SEC Form PRE 14C filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-pre-14c-filed-by-curanex-pharmaceuticals-inc-6609363)
- 2026-05-14 13:15 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-6552878)
- 2026-05-14 12:47 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-curanex-pharmaceuticals-inc-6552718)
- 2026-05-07 15:45 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-other-events-6538205)
- 2026-04-08 11:47 UTC [Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline](https://www.quantisnow.com/insight/curanex-highlights-five-additional-patient-cases-further-supporting-the-potential-6492178)
- 2026-04-06 13:17 UTC [Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care](https://www.quantisnow.com/insight/curanex-highlights-patient-case-study-supporting-potential-of-phyto-n-in-6488929)
- 2026-04-02 12:20 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-6483458)
- 2026-03-30 21:43 UTC [SEC Form 10-K] [SEC Form 10-K filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-curanex-pharmaceuticals-inc-6477071)
- 2026-03-18 12:00 UTC [Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission](https://www.quantisnow.com/insight/curanex-achieves-key-preclinical-milestone-with-favorable-toxicology-profile-at-6455127)
- 2026-03-12 13:30 UTC [Leadership Update] [Curanex Expands Scientific Advisory Board With Two Distinguished Researchers](https://www.quantisnow.com/insight/curanex-expands-scientific-advisory-board-with-two-distinguished-researchers-6443906)
- 2026-03-11 12:00 UTC [Leadership Update] [Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board](https://www.quantisnow.com/insight/curanex-appoints-two-veteran-industry-leaders-to-scientific-advisory-board-6441150)
- 2026-03-06 21:30 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-6435145)
- 2026-03-05 13:00 UTC [Curanex Forms World Class Scientific Advisory Board](https://www.quantisnow.com/insight/curanex-forms-world-class-scientific-advisory-board-6431532)
- 2026-02-25 13:00 UTC [Public Offering] [Curanex Provides Operational Update on Key Regulatory Milestones](https://www.quantisnow.com/insight/curanex-provides-operational-update-on-key-regulatory-milestones-6411926)
- 2026-01-05 20:43 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-financial-6334219)
- 2025-11-15 02:58 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-curanex-pharmaceuticals-inc-6281848)
- 2025-11-15 01:33 UTC [SEC Form NT 10-Q filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-curanex-pharmaceuticals-inc-6281832)
- 2025-11-06 18:40 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-notice-of-delisting-6264892)
- 2025-10-22 11:00 UTC [Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-engages-strategic-investor-relations-to-enhance-investor-6240774)
- 2025-09-29 19:55 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-unregistered-sales-of-6214331)
- 2025-09-12 18:53 UTC [SEC Form 8-K] [Curanex Pharmaceuticals Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-6199154)
- 2025-09-12 18:46 UTC [Public Offering] [Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-announces-exercise-of-the-over-allotment-option-by-6199147)
- 2025-09-09 19:28 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Curanex Pharmaceuticals Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-curanex-pharmaceuticals-inc-6194867)
- 2025-09-03 00:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hsu Helen Hong](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hsu-helen-hong-6186609)
- 2025-09-03 00:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Xie Liqin](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-xie-liqin-6186608)
- 2025-09-03 00:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Zhong Huijuan](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-zhong-huijuan-6186607)
- 2025-09-03 00:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Zhang Ning](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-zhang-ning-6186606)
- 2025-09-03 00:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hao Xiaohui](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hao-xiaohui-6186605)
- 2025-09-03 00:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Yan Yong](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-yan-yong-6186604)
- 2025-09-03 00:30 UTC [SEC Form 3] [New insider Jing Dian Ying claimed ownership of 11,237,160 shares and claimed ownership of 690,000 units of Series A Preferred Stock (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-jing-dian-ying-claimed-ownership-of-11237160-shares-6186603)
- 2025-09-03 00:30 UTC [SEC Form 3] [New insider Liu Chang claimed ownership of 310,000 units of Series A Preferred Stock and claimed ownership of 7,982,220 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-liu-chang-claimed-ownership-of-310000-units-of-6186602)
- 2025-09-03 00:30 UTC [SEC Form 3] [New insider Liu Jun claimed ownership of 11,237,160 shares and claimed ownership of 690,000 units of Series A Preferred Stock (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-liu-jun-claimed-ownership-of-11237160-shares-and-6186601)
- 2025-08-27 21:00 UTC [Public Offering] [Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering](https://www.quantisnow.com/insight/curanex-pharmaceuticals-inc-announces-closing-of-its-initial-public-offering-6181135)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CURX
- Earnings history: https://www.quantisnow.com/earnings/CURX
- Dividend history: https://www.quantisnow.com/dividends/CURX
- Insider transactions: https://www.quantisnow.com/insiders/CURX
- Options chain: https://www.quantisnow.com/options/CURX
- SEC 8-K filings only: https://www.quantisnow.com/company/CURX/8-k
- RSS and alerts for CURX: https://www.quantisnow.com/docs/rss-feeds.md
